Sources

12 Total Sources

Study Links GLP-1 Drugs to 30% Lower Breast Cancer Risk in 111,646 Women

springermedicine.com1d ago

Study Links GLP-1 Agonists to 30% Lower Breast Cancer Risk

GLP-1 drugs linked to lower cancer risk | Tulane Cancer Center posted on the topic | LinkedIn

Could GLP-1s Cure Breast Cancer?. The current it-girl of biotech, GLP-1s… | by Victoria Dmitruczyk | Jun, 2026 | Medium

GLP-1 & Gallbladder Disease: What Ozempic & Mounjaro Do to Your Gallbladder (Weightloss Dr Explains)

Nature.com1d ago

Effect of GLP-1 receptor agonists at doses for obesity management on muscle health: systematic review and meta-analysis of randomized controlled trials (RCTs) | International Journal of Obesity

Study of 100,000-plus women links GLP-1 use to 30% lower breast cancer risk

Healthline1d ago

Ozempic, Wegovy: GLP-1 Drugs Lower Breast Cancer Risk by 30%

Women on Ozempic-like drugs are 30% less likely to develop breast cancer: study - AOL

PBS NewsHour13h ago

GLP-1 Weight-Loss Drugs Ozempic and Wegovy Show Potential to Reduce Cancer Risk

GLP-1 drugs tied to lower breast cancer risk, new uses explored

Instagram1d ago

A new Penn Medicine study is drawing attention after researchers found that women taking GLP-1 medications had lower odds of developing breast cancer compared to women who were not taking the drugs.

The Lancet1d ago

Elecoglipron, an oral small molecule GLP-1 receptor agonist in adults with obesity or overweight (VISTA): a multicentre, phase 2, randomised, placebo-controlled clinical trial - The Lancet